Nuveen Asset Management, LLC Relay Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 653,428 shares of RLAY stock, worth $4.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

653,428

Previous 275,106 137.52%

Holding current value

$4.33 Million

Previous $1.95 Million 38.26%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.12 - $6.8 $1.56 Million - $2.57 Million	378,322 Added 137.52%	653,428 $2.69 Million
Q3 2024 Nov 14, 2024	SELL	$6.23 - $9.51 $1.07 Million - $1.63 Million	-171,702 Reduced 38.43%	275,106 $1.95 Million
Q2 2024 Aug 09, 2024	BUY	$5.9 - $8.02 $1.09 Million - $1.48 Million	184,925 Added 70.61%	446,808 $2.91 Million
Q4 2023 Feb 14, 2024	BUY	$6.01 - $11.48 $20,512 - $39,181	3,413 Added 1.32%	261,883 $2.88 Million
Q3 2023 Nov 14, 2023	SELL	$8.24 - $12.97 $13,282 - $20,907	-1,612 Reduced 0.62%	258,470 $2.17 Million

Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $91,358 - $167,079	9,145 Added 3.64%	260,082 $3.27 Million
Q1 2023 May 15, 2023	BUY	$15.0 - $22.76 $236,010 - $358,105	15,734 Added 6.69%	250,937 $4.13 Million
Q4 2022 Feb 14, 2023	SELL	$14.16 - $24.02 $551,886 - $936,179	-38,975 Reduced 14.22%	235,203 $3.51 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $78,279 - $135,894	4,332 Added 1.61%	274,178 $6.13 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $699,081 - $1.83 Million	52,523 Added 24.17%	269,846 $4.52 Million
Q1 2022 May 16, 2022	BUY	$20.26 - $32.36 $106,810 - $170,601	5,272 Added 2.49%	217,323 $5.63 Million
Q4 2021 Feb 14, 2022	SELL	$26.0 - $37.03 $56,342 - $80,244	-2,167 Reduced 1.01%	212,051 $5.93 Million
Q3 2021 Nov 12, 2021	BUY	$29.75 - $37.99 $199,533 - $254,798	6,707 Added 3.23%	214,218 $7.95 Million
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $1.4 Million - $1.95 Million	50,977 Added 32.57%	207,511 $7.59 Million
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $905,454 - $1.71 Million	27,843 Added 21.64%	156,534 $5.41 Million
Q4 2020 Feb 16, 2021	BUY	$35.51 - $54.03 $94,172 - $143,287	2,652 Added 2.1%	128,691 $5.35 Million
Q3 2020 Nov 16, 2020	BUY	$32.81 - $45.1 $4.14 Million - $5.68 Million	126,039 New	126,039 $5.37 Million

Others Institutions Holding RLAY

# of Institutions

216

Shares Held

168M

Call Options Held

714K

Put Options Held

14.9K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $796M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Relay Therapeutics, Inc. Transaction History